Table 1 Clinical characteristics of the study subjects

BMI (kg/m2 ± SD)

24.22 ± 3.50

23.97 ± 4.34

1.0002(0.9995–1.0009)

0.6313

Gender, n (%)

Male

48(39.67%)

70(65.42%)

1.0106(1.0052–1.0161)

0.0001

Female

73(60.33%)

37(34.58%)

History

Family history of gallbladder stone, n (%)

35(28.93%)

10(9.35%)

1.0138(1.0061–1.0215)

0.0004

Smoking, n (%)^a

17(14.05%)

21(19.63%)

0.996(0.9891–1.003)

0.2614

Alcohol drinking, n (%)^b

6(4.96%)

9(8.41%)

0.9944(0.9838–1.005)

0.2992

Regular sports, n (%)^c

24(19.84%)

40(37.38%)

0.9912(0.9854–0.9971)

0.0037

Regular breakfast, n (%)^d

88(72.73%)

90(84.11%)

0.9932(0.9866–0.9996)

0.0401

Diabetes, n (%)

12(9.92%)

4(3.74%)

1.0105(0.9988–1.0223)

0.0791

Hypertension, n (%)

26(21.49%)

21(19.63%)

1.0011(0.9947–1.0076)

0.7289

Antilipemic agents, n (%)

9(7.44%)

1(0.93%)

1.0217(1.0006–1.0431)

0.0438

LDL (mmol/L ± SD)

2.62 ± 0.72

2.62 ± 0.72

0.9999(0.9958–1.004)

0.9741

HDL (mmol/L ± SD)

1.19 ± 0.34

1.25 ± 0.31

0.9949(0.9858–1.0041)

0.2725

TC (mmol/L ± SD)

4.31 ± 0.82

4.35 ± 0.85

0.9994(0.9958–1.003)

0.7555

TG (mmol/L ± SD)

1.39 ± 0.67

1.4 ± 0.85

0.9998(0.9958–1.0038)

0.934

DBIL (umol/L ± SD)

5.18 ± 6.42

3.85 ± 1.58

1.0008(0.9999–1.0017)

0.0733

IBIL (umol/L ± SD)

8.49 ± 11.17

7.86 ± 3.77

1.0001(0.9997–1.0005)

0.5944

TBIL (umol/L ± SD)

13.72 ± 13.92

11.7 ± 5.19

1.0002(0.9999–1.0005)

0.1866

Number of stones, n (%)

Single-shot

34(28.1%)

Frequent

87(71.9%)

Stone diameter

(mm ± SD)

10.51 ± 7.80